axios.com web signal

Trase Raises $107M Seed for Healthcare and Defense AI Agents

TL;DR

  • Trase raised $107 million in a seed round led by Arch Venture Partners for AI agent infrastructure targeting healthcare and defense.
  • The Northern Virginia startup counts Duke Health and the U.S. Navy among its current customers.
  • Trase charges clients based on operational efficiency gains rather than upfront software fees.

Raising $107 million before a Series A is unusual enough to signal real conviction. Raising it specifically for AI agent infrastructure in healthcare and defense, two sectors where a wrong answer from an AI system carries serious consequences, signals a more specific bet about where the durable AI infrastructure opportunities actually are. Axios Pro reported that Trase, a Northern Virginia startup, closed the round led by Arch Venture Partners, with CEO Grant Verstandig sharing the news exclusively.

Trase, co-founded by Verstandig and Joe Laws, builds what it describes as an operating system for AI agents: a layer that handles orchestration, governance, and security across cloud, on-premises, and edge environments. The company's early customers include Duke Health and the U.S. Navy. When Trase emerged from stealth in November 2025 with a $10.5 million pre-seed, Technical.ly reported that a deployment at Duke Health produced three times faster prescription refill turnaround and $193,000 in annual savings.

The business model is the distinctive feature here. Trase does not charge upfront; it bills based on how much more efficient its clients' operations become. That structure makes it easier for a risk-averse health system or federal procurement office to say yes to a pilot, but it also means revenue recognition is tied to demonstrated outcomes, which can be slow and subject to attribution disputes at scale.

What the reporting does not give you is Trase's valuation, the specific nature of its Navy relationship, or the split between healthcare and defense revenue. Arch Venture Partners has deep health-tech deal flow, and their lead position is a credible signal for the healthcare side. Whether that signal extends to the defense contracts, which run on entirely different procurement and compliance tracks, is the open question going forward. For health systems and defense agencies whose administrative workloads keep growing, a vendor whose fee depends on whether the AI actually helps is an easier conversation than most.